|
1
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: Epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hernandez-Gea V, Toffanin S, Friedman SL
and Llovet JM: Role of the microenvironment in the pathogenesis and
treatment of hepatocellular carcinoma. Gastroenterology.
144:512–527. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bruix J, Gores GJ and Mazzaferro V:
Hepatocellular carcinoma: Clinical frontiers and perspectives. Gut.
63:844–855. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Villanueva A, Hernandez-Gea V and Llovet
JM: Medical therapies for hepatocellular carcinoma: A critical view
of the evidence. Nat Rev Gastroenterol Hepatol. 10:34–42. 2013.
View Article : Google Scholar
|
|
5
|
Huber MA, Kraut N and Beug H: Molecular
requirements for epithelial-mesenchymal transition during tumor
progression. Curr Opin Cell Biol. 17:548–558. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Thompson EW, Newgreen DF and Tarin D:
Carcinoma invasion and metastasis: A role for
epithelial-mesenchymal transition? Cancer Res. 65:5991–5995. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ruan K, Song G and Ouyang G: Role of
hypoxia in the hallmarks of human cancer. J Cell Biochem.
107:1053–1062. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yan W, Fu Y, Tian D, Liao J, Liu M, Wang
B, Xia L, Zhu Q and Luo M: PI3 kinase/Akt signaling mediates
epithelial-mesenchymal transition in hypoxic hepatocellular
carcinoma cells. Biochem Biophys Res Commun. 382:631–636. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jing Y, Han Z, Zhang S, Liu Y and Wei L:
Epithelial-mesenchymal transition in tumor microenvironment. Cell
Biosci. 1:292011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang L, Huang G, Li X, Zhang Y, Jiang Y,
Shen J, Liu J, Wang Q, Zhu J, Feng X, et al: Hypoxia induces
epithelial-mesenchymal transition via activation of SNAI1 by
hypoxia-inducible factor-1α in hepatocellular carcinoma. BMC
Cancer. 13:1082013. View Article : Google Scholar
|
|
11
|
Saitoh T and Katoh M: FRAT1 and FRAT2,
clustered in human chromosome 10q24.1 region, are up-regulated in
gastric cancer. Int J Oncol. 19:311–315. 2001.PubMed/NCBI
|
|
12
|
Jonkers J, Korswagen HC, Acton D, Breuer M
and Berns A: Activation of a novel proto-oncogene, Frat1,
contributes to progression of mouse T-cell lymphomas. EMBO J.
16:441–450. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang Y, Yu J-H, Lin X-Y, Miao Y, Han Y,
Fan CF, Dong XJ, Dai SD and Wang EH: Overexpression of Frat1
correlates with malignant phenotype and advanced stage in human
non-small cell lung cancer. Virchows Arch. 459:255–263. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang Y, Liu S, Zhu H, Zhang W, Zhang G,
Zhou X, Zhou C, Quan L, Bai J, Xue L, et al: FRAT1 overexpression
leads to aberrant activation of β-catenin/TCF pathway in esophageal
squamous cell carcinoma. Int J Cancer. 123:561–568. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Guo G, Liu B, Zhong C, Zhang X, Mao X,
Wang P, Jiang X, Huo J, Jin J, Liu X, et al: FRAT1 expression and
its correlation with pathologic grade, proliferation, and apoptosis
in human astrocytomas. Med Oncol. 28:1–6. 2011. View Article : Google Scholar
|
|
16
|
Guo G, Kuai D, Cai S, Xue N, Liu Y, Hao J,
Fan Y, Jin J, Mao X, Liu B, et al: Knockdown of FRAT1 expression by
RNA interference inhibits human glioblastoma cell growth, migration
and invasion. PLoS One. 8:e612062013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kong D, Li Y, Wang Z and Sarkar FH: Cancer
stem cells and epithelial-to-mesenchymal transition
(EMT)-phenotypic cells: Are they cousins or twins? Cancers (Basel).
3:716–729. 2011. View Article : Google Scholar
|
|
18
|
Jiao M and Nan K-J: Activation of PI3
kinase/Akt/HIF-1α pathway contributes to hypoxia-induced
epithelial-mesenchymal transition and chemoresistance in
hepatocellular carcinoma. Int J Oncol. 40:461–468. 2012.
|
|
19
|
Bengochea A, de Souza MM, Lefrançois L, Le
Roux E, Galy O, Chemin I, Kim M, Wands JR, Trepo C, Hainaut P, et
al: Common dysregulation of Wnt/Frizzled receptor elements in human
hepatocellular carcinoma. Br J Cancer. 99:143–150. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lee HC, Kim M and Wands JR: Wnt/Frizzled
signaling in hepatocellular carcinoma. Front Biosci. 11:1901–1915.
2006. View Article : Google Scholar
|
|
21
|
Merle P, de la Monte S, Kim M, Herrmann M,
Tanaka S, Von Dem Bussche A, Kew MC, Trepo C and Wands JR:
Functional consequences of frizzled-7 receptor overexpression in
human hepatocellular carcinoma. Gastroenterology. 127:1110–1122.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu J, Ding X, Tang J, Cao Y, Hu P, Zhou
F, Shan X, Cai X, Chen Q, Ling N, et al: Enhancement of canonical
Wnt/β-catenin signaling activity by HCV core protein promotes cell
growth of hepatocellular carcinoma cells. PLoS One. 6:e274962011.
View Article : Google Scholar
|
|
23
|
Thompson MD and Monga SP: WNT/β-catenin
signaling in liver health and disease. Hepatology. 45:1298–1305.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Onder TT, Gupta PB, Mani SA, Yang J,
Lander ES and Weinberg RA: Loss of E-cadherin promotes metastasis
via multiple downstream transcriptional pathways. Cancer Res.
68:3645–3654. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Conacci-Sorrell M, Simcha I, Ben-Yedidia
T, Blechman J, Savagner P and Ben-Ze'ev A: Autoregulation of
E-cadherin expression by cadherin-cadherin interactions: The roles
of β-catenin signaling, Slug, and MAPK. J Cell Biol. 163:847–857.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jin R, Liu W, Menezes S, Yue F, Zheng M,
Kovacevic Z and Richardson DR: The metastasis suppressor NDRG1
modulates the phosphorylation and nuclear translocation of
β-catenin through mechanisms involving FRAT1 and PAK4. J Cell Sci.
127:3116–3130. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Demir R, Dimmler A, Naschberger E, Demir
I, Papadopoulos T, Melling N, Sturzl M and Hohenberger W: Malignant
progression of invasive tumour cells seen in hypoxia present an
accumulation of β-catenin in the nucleus at the tumour front. Exp
Mol Pathol. 87:109–116. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Choi H, Chun Y-S, Kim T-Y and Park J-W:
HIF-2α enhances β-catenin/TCF-driven transcription by interacting
with β-catenin. Cancer Res. 70:10101–10111. 2010. View Article : Google Scholar : PubMed/NCBI
|
